nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethanolamine Oleate—FABP5—skin epidermis—psoriasis	0.13	0.539	CbGeAlD
Ethanolamine Oleate—FABP5—skin of body—psoriasis	0.0402	0.167	CbGeAlD
Ethanolamine Oleate—FABP4—skin of body—psoriasis	0.0376	0.156	CbGeAlD
Ethanolamine Oleate—FABP4—tendon—psoriasis	0.0287	0.119	CbGeAlD
Ethanolamine Oleate—Lacrimation increased—Beclomethasone—psoriasis	0.0206	0.0371	CcSEcCtD
Ethanolamine Oleate—F12—Levonorgestrel—Hydrocortisone—psoriasis	0.0205	1	CbGdCrCtD
Ethanolamine Oleate—Ulcer—Beclomethasone—psoriasis	0.0201	0.0362	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Fluocinolone Acetonide—psoriasis	0.02	0.036	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Mycophenolate mofetil—psoriasis	0.0168	0.0302	CcSEcCtD
Ethanolamine Oleate—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.0155	0.0845	CbGpPWpGaD
Ethanolamine Oleate—Oesophageal ulcer—Hydrocortisone—psoriasis	0.0153	0.0275	CcSEcCtD
Ethanolamine Oleate—Retrosternal pain—Mycophenolate mofetil—psoriasis	0.0152	0.0273	CcSEcCtD
Ethanolamine Oleate—Abscess—Fluocinolone Acetonide—psoriasis	0.0148	0.0267	CcSEcCtD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.0145	0.079	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—SERPINB8—psoriasis	0.0137	0.0749	CbGpPWpGaD
Ethanolamine Oleate—Oesophageal ulcer—Betamethasone—psoriasis	0.013	0.0235	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Dexamethasone—psoriasis	0.013	0.0235	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Fluocinolone Acetonide—psoriasis	0.0127	0.023	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Prednisone—psoriasis	0.0114	0.0205	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Acitretin—psoriasis	0.0108	0.0194	CcSEcCtD
Ethanolamine Oleate—Pain—Calcipotriol—psoriasis	0.0102	0.0184	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Mycophenolic acid—psoriasis	0.0101	0.0182	CcSEcCtD
Ethanolamine Oleate—Abscess—Mycophenolic acid—psoriasis	0.00979	0.0176	CcSEcCtD
Ethanolamine Oleate—FABP4—Lipid and lipoprotein metabolism—APOE—psoriasis	0.00979	0.0533	CbGpPWpGaD
Ethanolamine Oleate—Ulcer—Hydroxyurea—psoriasis	0.00978	0.0176	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00961	0.0524	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—IL10—psoriasis	0.00909	0.0495	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—IL4—psoriasis	0.00884	0.0482	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—HLA-A—psoriasis	0.00801	0.0436	CbGpPWpGaD
Ethanolamine Oleate—Pleural effusion—Mycophenolate mofetil—psoriasis	0.00798	0.0144	CcSEcCtD
Ethanolamine Oleate—Abscess—Cyclosporine—psoriasis	0.00792	0.0143	CcSEcCtD
Ethanolamine Oleate—Abscess—Mycophenolate mofetil—psoriasis	0.00772	0.0139	CcSEcCtD
Ethanolamine Oleate—Pain—Tazarotene—psoriasis	0.00751	0.0135	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Hydroxyurea—psoriasis	0.00727	0.0131	CcSEcCtD
Ethanolamine Oleate—Abscess—Prednisolone—psoriasis	0.00721	0.013	CcSEcCtD
Ethanolamine Oleate—Necrosis—Hydrocortisone—psoriasis	0.00709	0.0128	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Mycophenolic acid—psoriasis	0.00708	0.0128	CcSEcCtD
Ethanolamine Oleate—Abscess—Hydrocortisone—psoriasis	0.00704	0.0127	CcSEcCtD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	0.00693	0.0377	CbGpPWpGaD
Ethanolamine Oleate—Lacrimation increased—Cyclosporine—psoriasis	0.0068	0.0123	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Beclomethasone—psoriasis	0.00678	0.0122	CcSEcCtD
Ethanolamine Oleate—Abscess—Triamcinolone—psoriasis	0.00663	0.0119	CcSEcCtD
Ethanolamine Oleate—Pain—Clobetasol propionate—psoriasis	0.00637	0.0115	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Mycophenolic acid—psoriasis	0.00609	0.011	CcSEcCtD
Ethanolamine Oleate—Necrosis—Betamethasone—psoriasis	0.00606	0.0109	CcSEcCtD
Ethanolamine Oleate—Necrosis—Dexamethasone—psoriasis	0.00606	0.0109	CcSEcCtD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	0.00603	0.0329	CbGpPWpGaD
Ethanolamine Oleate—Abscess—Dexamethasone—psoriasis	0.00601	0.0108	CcSEcCtD
Ethanolamine Oleate—Abscess—Betamethasone—psoriasis	0.00601	0.0108	CcSEcCtD
Ethanolamine Oleate—Pain—Beclomethasone—psoriasis	0.00579	0.0104	CcSEcCtD
Ethanolamine Oleate—Pain—Fluocinonide—psoriasis	0.00574	0.0103	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Cyclosporine—psoriasis	0.00572	0.0103	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Mycophenolate mofetil—psoriasis	0.00558	0.0101	CcSEcCtD
Ethanolamine Oleate—Ulcer—Triamcinolone—psoriasis	0.00554	0.00999	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—IFNG—psoriasis	0.00534	0.0291	CbGpPWpGaD
Ethanolamine Oleate—Necrosis—Prednisone—psoriasis	0.00528	0.00951	CcSEcCtD
Ethanolamine Oleate—Abscess—Prednisone—psoriasis	0.00524	0.00944	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Hydrocortisone—psoriasis	0.00509	0.00917	CcSEcCtD
Ethanolamine Oleate—Ulcer—Betamethasone—psoriasis	0.00503	0.00906	CcSEcCtD
Ethanolamine Oleate—Ulcer—Dexamethasone—psoriasis	0.00503	0.00906	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—CXCL8—psoriasis	0.00497	0.0271	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Calcitriol—psoriasis	0.00493	0.00888	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Mycophenolate mofetil—psoriasis	0.00481	0.00866	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Calcitriol—psoriasis	0.00472	0.00851	CcSEcCtD
Ethanolamine Oleate—CYP2E1—tendon—psoriasis	0.00469	0.0195	CbGeAlD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—JUN—psoriasis	0.00462	0.0252	CbGpPWpGaD
Ethanolamine Oleate—Pleural effusion—Methotrexate—psoriasis	0.00452	0.00815	CcSEcCtD
Ethanolamine Oleate—Necrosis—Methotrexate—psoriasis	0.00441	0.00795	CcSEcCtD
Ethanolamine Oleate—Chest pain—Acitretin—psoriasis	0.00438	0.0079	CcSEcCtD
Ethanolamine Oleate—Ulcer—Prednisone—psoriasis	0.00438	0.00789	CcSEcCtD
Ethanolamine Oleate—Abscess—Methotrexate—psoriasis	0.00438	0.00789	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Mycophenolic acid—psoriasis	0.00436	0.00785	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Dexamethasone—psoriasis	0.00435	0.00783	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Betamethasone—psoriasis	0.00435	0.00783	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Methoxsalen—psoriasis	0.00419	0.00755	CcSEcCtD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	0.00412	0.0224	CbGpPWpGaD
Ethanolamine Oleate—Pain—Calcitriol—psoriasis	0.00404	0.00728	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—ITGAL—psoriasis	0.00399	0.0217	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00399	0.0217	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00394	0.0215	CbGpPWpGaD
Ethanolamine Oleate—Oesophagitis—Prednisone—psoriasis	0.00379	0.00682	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Calcitriol—psoriasis	0.00373	0.00673	CcSEcCtD
Ethanolamine Oleate—Ulcer—Methotrexate—psoriasis	0.00366	0.0066	CcSEcCtD
Ethanolamine Oleate—Pain—Acitretin—psoriasis	0.00359	0.00648	CcSEcCtD
Ethanolamine Oleate—Pain—Fluocinolone Acetonide—psoriasis	0.00358	0.00646	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Cyclosporine—psoriasis	0.00353	0.00635	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Mycophenolate mofetil—psoriasis	0.00344	0.0062	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Acitretin—psoriasis	0.00332	0.00599	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.00331	0.00597	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—CARM1—psoriasis	0.00328	0.0179	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00323	0.0176	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—TNF—psoriasis	0.0032	0.0175	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NDUFA5—psoriasis	0.00314	0.0171	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—TP53—psoriasis	0.00305	0.0166	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.00293	0.0159	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Mycophenolic acid—psoriasis	0.00288	0.00519	CcSEcCtD
Ethanolamine Oleate—Pain—Hydroxyurea—psoriasis	0.00282	0.00508	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—IL6—psoriasis	0.00279	0.0152	CbGpPWpGaD
Ethanolamine Oleate—Renal failure acute—Methotrexate—psoriasis	0.00272	0.00491	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—CYP2S1—psoriasis	0.00267	0.0145	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Hydroxyurea—psoriasis	0.00261	0.0047	CcSEcCtD
Ethanolamine Oleate—Pain—Mycophenolic acid—psoriasis	0.00236	0.00426	CcSEcCtD
Ethanolamine Oleate—Chest pain—Cyclosporine—psoriasis	0.00233	0.0042	CcSEcCtD
Ethanolamine Oleate—Chest pain—Mycophenolate mofetil—psoriasis	0.00227	0.0041	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Cyclosporine—psoriasis	0.00224	0.00403	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Mycophenolic acid—psoriasis	0.00218	0.00394	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.00218	0.00393	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Prednisolone—psoriasis	0.00203	0.00367	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Hydrocortisone—psoriasis	0.00199	0.00358	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Methotrexate—psoriasis	0.00195	0.00351	CcSEcCtD
Ethanolamine Oleate—Pain—Cyclosporine—psoriasis	0.00191	0.00344	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Triamcinolone—psoriasis	0.00187	0.00337	CcSEcCtD
Ethanolamine Oleate—Pain—Mycophenolate mofetil—psoriasis	0.00186	0.00336	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00183	0.00999	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Cyclosporine—psoriasis	0.00177	0.00318	CcSEcCtD
Ethanolamine Oleate—Pain—Prednisolone—psoriasis	0.00174	0.00313	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Mycophenolate mofetil—psoriasis	0.00172	0.00311	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.00172	0.00936	CbGpPWpGaD
Ethanolamine Oleate—Pain—Hydrocortisone—psoriasis	0.0017	0.00306	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Betamethasone—psoriasis	0.0017	0.00306	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Dexamethasone—psoriasis	0.0017	0.00306	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.00169	0.00923	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—NOS2—psoriasis	0.00164	0.00892	CbGpPWpGaD
Ethanolamine Oleate—Pain—Triamcinolone—psoriasis	0.0016	0.00288	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Hydrocortisone—psoriasis	0.00157	0.00283	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—LEP—psoriasis	0.00157	0.00853	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.00148	0.00808	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Triamcinolone—psoriasis	0.00148	0.00266	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Prednisone—psoriasis	0.00148	0.00266	CcSEcCtD
Ethanolamine Oleate—Pain—Betamethasone—psoriasis	0.00145	0.00262	CcSEcCtD
Ethanolamine Oleate—Pain—Dexamethasone—psoriasis	0.00145	0.00262	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.0014	0.00762	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—PPARG—psoriasis	0.00136	0.00743	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Dexamethasone—psoriasis	0.00134	0.00242	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Betamethasone—psoriasis	0.00134	0.00242	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—CARM1—psoriasis	0.0013	0.0071	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Methotrexate—psoriasis	0.00129	0.00232	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00128	0.00696	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Methotrexate—psoriasis	0.00124	0.00223	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.00122	0.00664	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—TYK2—psoriasis	0.0012	0.00651	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Prednisone—psoriasis	0.00117	0.00211	CcSEcCtD
Ethanolamine Oleate—Pain—Methotrexate—psoriasis	0.00106	0.0019	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Methotrexate—psoriasis	0.000976	0.00176	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—VEGFA—psoriasis	0.000949	0.00517	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—NFKB1—psoriasis	0.000931	0.00507	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—VEGFA—psoriasis	0.000845	0.00461	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—STAT3—psoriasis	0.000837	0.00456	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CAT—psoriasis	0.000802	0.00437	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—TNF—psoriasis	0.000724	0.00395	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—TP53—psoriasis	0.000717	0.00391	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—APOE—psoriasis	0.000623	0.00339	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—IL6—psoriasis	0.000585	0.00319	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PPARG—psoriasis	0.000542	0.00296	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NDUFA5—psoriasis	0.000346	0.00188	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP2S1—psoriasis	0.000294	0.0016	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CARM1—psoriasis	0.000143	0.000782	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CAT—psoriasis	8.83e-05	0.000481	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—APOE—psoriasis	6.86e-05	0.000374	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PPARG—psoriasis	5.97e-05	0.000325	CbGpPWpGaD
